Spectranetics touts Stellarex drug-eluting balloon data

Spectranetics touts 2-year data from a study of the Stellarex drug-eluting balloon it bought from Covidien earlier this year.

Covidien, Medtronic, Spectranetics Corp.

News Well, Clinical Trials, Drug-Eluting Balloons, Peripheral Artery Disease

read more

from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1cVnqBp